Skip to content
Open access

Sleep disturbances in Parkinson’s disease: distinct impacts of nocturnal sleep and daytime sleepiness on quality of life

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, among which sleep disorders stand out, including nocturnal alterations and excessive daytime sleepiness (EDS). These changes may result from the disease itself or from dopaminergic therapies and are associated with functional impairment, increased risk of accidents, and, notably, worse quality of life (QoL). Objective: To evaluate the association between nocturnal sleep disturbances and daytime sleepiness (DS), measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2) and the Epworth Sleepiness Scale (ESS), respectively, and QoL, assessed by the Parkinson’s Disease Questionnaire-39 (PDQ-39), in patients with PD. Methods: A cross-sectional study conducted in a movement disorders outpatient clinic in Cuiabá, MT, including 44 patients with PD (4 excluded due to missing data). Sociodemographic and clinical variables were described using mean and standard deviation. Nocturnal sleep disturbances were assessed using the PDSS-2, with scores ≥18 suggesting the presence of sleep disorders, and DS was evaluated using the ESS, with scores ≥10 indicating EDS. QoL was measured using the PDQ-39 (global score and domains), described by median and interquartile range (IQR). Associations between sleep measures and QoL were analyzed using Spearman’s correlation (p<0.05). Results: The final sample (n=40) included 28 men (70%) and 12 women (30%), with a mean age of 59.7±9.9 years and a mean disease duration (n=39) of 10.7±4.4 years. Nocturnal sleep disturbances were identified in 72.5% of patients and EDS in 57.5%. In the isolated analysis of the PDQ-39, the median global score was 47.58 (IQR=41.12), while the most affected domains were mobility 63.75 (IQR=60.63) and emotional well-being 60.42 (IQR=58.33). Regarding associations, a moderate positive correlation was observed between nocturnal sleep disturbances and worse global QoL (ρ=0.55), with stronger associations in the domains of emotional well-being (ρ=0.65), bodily discomfort (ρ=0.58), and activities of daily living (ρ=0.43). The correlation between DS and global QoL was also positive (ρ=0.39), with stronger associations in cognition (ρ=0.46), communication (ρ=0.42), and activities of daily living (ρ=0.35). All correlations had p<0.05. Conclusion: Sleep disturbances are highly prevalent in patients with PD and are significantly associated with worse QoL. In this sample, a differential impact pattern was observed, in which nocturnal sleep disturbances were more related to emotional and physical aspects, while DS was more associated with cognitive and communicative impairments. The concurrent influence on activities of daily living reinforces the impact of these alterations on functionality. These findings highlight the importance of integrated assessment of sleep disturbances in clinical practice, contributing to the development of therapeutic strategies aimed at optimizing QoL.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.